Promising antibody drug provides hope for those with type 1 diabetes
Type 1 diabetes, a disorder in which the immune system attacks insulin-producing cells, has long been difficult to treat effectively. However, researchers at Johns Hopkins Medicine discovered a potential game-changer: mAb43, a novel antibody medication designed to prevent and potentially reverse Read More...